CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	3 Months Ended
	Oct. 31, 2014	Oct. 31, 2013
Cash Flows From Operating Activities:
Net (loss)/income	$ 49,623	$ 530,094
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	115,912	101,995
Stock compensation expense		262,871
Common stock issued for services rendered	21,050	168,500
Gain on disposal of property and equipment		(188,869)
Common stock issued as make-whole payments on preferred stock	58,523	151,200
Change in fair value of derivative liabilities	(711,978)	(1,877,287)
Changes in operating assets and liabilities
Accounts payable and accrued expenses	(601,072)	(129,974)
Deferred revenue		(984)
Other current assets	32,294	(10,617)
Net Cash Used in Operating Activities	(1,035,648)	(993,071)
Cash Flows From Investing Activities:
Proceeds from sale of property and equipment		883,780
Costs incurred for patents	(13,887)	(14,732)
Net Cash (Used in)/Provided By Investing Activities	(13,887)	869,048
Cash Flows From Financing Activities:
Proceeds from issuance of long-term debt
Repayment of long-term debt		(612,130)
Proceeds from exercise of warrants, net		65,000
Proceeds from exercise of stock options	542
Net Cash Provided by Financing Activities	542	(547,130)
Effect of Exchange Rates on Cash	(5,058)	(3,607)
Net Decrease in Cash and Cash Equivalents	(1,054,051)	(674,760)
Cash and Cash Equivalents, Beginning of Period	3,269,489	1,708,954
Cash and Cash Equivalents, End of Period	2,215,438	1,034,194
Supplemental Disclosure of Cash Flow Information
Interest paid in cash		$ 35,541